Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2006-10-10
2006-10-10
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S143100, C424S085400, C530S387100, C530S387300, C530S388200
Reexamination Certificate
active
07118742
ABSTRACT:
A novel polypeptide ligand, p30, or LIGHT, for herpes virus entry mediator, HVEM, is provided. LIGHT is useful for modulating immune responses and in inhibiting infection and/or subsequent proliferation by herpesvirus. HVEM fusion proteins are also provided. Methods for treating subjects with lymphoid cell disorders, tumors, autoimmune diseases, inflammatory disorders or those having or suspected of having a herpesvirus infection, utilizing p30 and the fusion proteins of the invention, are also provided.
REFERENCES:
patent: WO 96/22788 (1996-08-01), None
Anderson et al, Antivrial Research 21: 343-355, 1993.
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Kuby et al., 1994, Immunology, second edition, pp. 85-96.
Abaza et al, J of Protein Chemistry 11(5): 433-444, 1992.
Van Noort et al, International Reivew of Cytology 178: 127-205, 1998.
Bodey et al., Anticancer Research 20: 2665-2676, 2000.
Ezzell et al., Journal of NIH Research 7: 46-49, 1995.
Spitler et al., Cancer Biotherapy 10: 1-3, 1995.
Ramsay et al, JAMA 282 (21): 1992-1994; 1999.
Norberg et al, J Virology 78(19): 10755-70764.
Whitley et al, p. 2302, in Fields Virology, vol. 2, Third edition, Lippincott-Raven publication 1996.
Britt et al, p. 2493, in Fields Virology, vol. 2, Third edition, Lippincott-Raven publication 1996.
Chan Christina
Huynh Phuong N
La Jolla Institute for Allergy and Immunology
Pillsbury Winthrop Shaw & Pittman LLP
LandOfFree
Ligand for herpes simplex virus entry mediator and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ligand for herpes simplex virus entry mediator and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ligand for herpes simplex virus entry mediator and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3681665